SCHEMBL6663759

SCHEMBL6663759

O=C(O)Oc1ccnn1-c1cccs1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.38
PIM1 P11309 1/20 0.35
PIM3 Q86V86 1/20 0.35
PLK3 Q9H4B4 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
DAO P14920 1/20 0.35
ALDH1A1 P00352 3/20 0.34
CYP2C19 P33261 1/20 0.34
PLA2G7 Q13093 1/20 0.34
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
KDM4E B2RXH2 3/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
ALOX15 P16050 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6663757 0.80 DAO (0.41) HCAR2PIM1PIM3PLK3PIM2
SCHEMBL29629574 0.75 PIM1 (0.41) HCAR2PIM1PIM3PLK3PIM2
SCHEMBL3417583 0.74 POLB (0.50) CYP2C19KDM5AKDM4CKDM5BKMT2A
SCHEMBL1906407 0.70 LMNA (0.39) ALDH1A1CYP2C19KDM5AKDM4CKDM5B
SCHEMBL28792402 0.69 CA12 (0.42) ALDH1A1CYP2C19KMT2ANPC1RAB9A
SCHEMBL3427273 0.68 SMN1; SMN2 (0.40) ALDH1A1CYP2C19KDM5AKDM4CKDM5B
SCHEMBL1036006 0.65
Hydrochloric Acid SCHEMBL11517510 0.64 MMP1 (0.49) HCAR2DAOALDH1A1CYP2C19PLA2G7
SCHEMBL8694456 0.63 GRM4 (0.36) PIM1PIM3PLK3PIM2ALDH1A1
SCHEMBL6272120 0.61 MAPK1 (0.35) ALDH1A1KDM5AKDM4CKDM5BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1441721-A2 USE OF ENDOTHELIN RECEPTOR ANTAGONISTS IN THE TREATMENT OF TUMOUR DISEASES MERCK PATENT GmbH (DE) 2004-08-04 EP claimed
WO-2003039539-A2 USE OF ENDOTHELIN RECEPTOR ANTAGONISTS IN THE TREATMENT OF TUMOUR DISEASES MERCK PATENT GMBH (DE) 2003-05-15 WO claimed